R. Mannhold et al., NEW CALMODULIN ANTAGONISTS OF THE DIPHENYLALKYLAMINE TYPE .1. BIOLOGICAL-ACTIVITY, SAR AND THE ROLE OF LIPOPHILICITY, European journal of medicinal chemistry, 28(9), 1993, pp. 727-734
Potency and selectivity of currently available calmodulin (CaM) antago
nists is rather limited. We attempted to improve the CaM-antagonistic
activity in a new series of analogues of the CaM-antagonist prenylamin
e. The biological test system used was the CaM-stimulated phosphodiest
erase. Insertion of a double bond or heteroatoms (O, S) at the ring co
nnecting carbon in the benzhydryl part of the molecule increases poten
cy in comparison to the lead compound prenylamine. Chain length is opt
imal with 4 atoms-nitrogen-3 atoms. Regarding benzhydryl substitution,
halogenation results in a significantly increased improvement of CaM-
inhibitory potency than methylation; parasubstitution is superior to o
rtho-substitution. Secondary nitrogen seems to be advantageous as comp
ared to tertiary amine. Lipophilicity has been detected as a prime phy
sico-chemical descriptor of CaM-antagonistic potency. The role of lipo
philicity, however, differs in a quantitative sense when the subgroups
are considered. It decreases within the subgroups in the following ma
nner: saturated alkyl chain- > double bond- > sulphur- > oxygen-deriva
tives. Amongst the compounds described, new CaM-antagonists with remar
kably high potency have been detected.